Rooke Nanette, Markovtsov Vadim, Cagavi Esra, Black Douglas L
Department of Microbiology, Immunology and Molecular Genetics, University of California-Los Angeles, 1602 Molecular Sciences Building, 405 Hilgard Avenue, Los Angeles, CA 90095, USA.
Mol Cell Biol. 2003 Mar;23(6):1874-84. doi: 10.1128/MCB.23.6.1874-1884.2003.
The splicing of the c-src exon N1 is controlled by an intricate combination of positive and negative RNA elements. Most previous work on these sequences focused on intronic elements found upstream and downstream of exon N1. However, it was demonstrated that the 5' half of the N1 exon itself acts as a splicing enhancer in vivo. Here we examine the function of this regulatory element in vitro. We show that a mutation in this sequence decreases splicing of the N1 exon in vitro. Proteins binding to this element were identified as hnRNP A1, hnRNP H, hnRNP F, and SF2/ASF by site-specific cross-linking and immunoprecipitation. The binding of these proteins to the RNA was eliminated by a mutation in the exonic element. The activities of hnRNP A1 and SF2/ASF on N1 splicing were examined by adding purified protein to in vitro splicing reactions. SF2/ASF and another SR protein, SC35, are both able to stimulate splicing of c-src pre-mRNA. However, splicing activation by SF2/ASF is dependent on the N1 exon enhancer element whereas activation by SC35 is not. In contrast to SF2/ASF and in agreement with other systems, hnRNP A1 repressed c-src splicing in vitro. The negative activity of hnRNP A1 on splicing was compared with that of PTB, a protein previously demonstrated to repress splicing in this system. Both proteins repress exon N1 splicing, and both counteract the enhancing activity of the SR proteins. Removal of the PTB binding sites upstream of N1 prevents PTB-mediated repression but does not affect A1-mediated repression. Thus, hnRNP A1 and PTB use different mechanisms to repress c-src splicing. Our results link the activity of these well-known exonic splicing regulators, SF2/ASF and hnRNP A1, to the splicing of an exon primarily controlled by intronic factors.
c-src外显子N1的剪接受正向和负向RNA元件的复杂组合控制。此前关于这些序列的大多数研究都集中在外显子N1上下游的内含子元件上。然而,有研究表明,N1外显子自身的5'端在体内可作为剪接增强子。在此,我们在体外研究了该调控元件的功能。我们发现该序列中的一个突变会降低体外N1外显子的剪接效率。通过位点特异性交联和免疫沉淀鉴定出与该元件结合的蛋白质为hnRNP A1、hnRNP H、hnRNP F和SF2/ASF。外显子元件中的一个突变消除了这些蛋白质与RNA的结合。通过向体外剪接反应中添加纯化蛋白,研究了hnRNP A1和SF2/ASF对N1剪接的活性。SF2/ASF和另一种SR蛋白SC35都能够刺激c-src前体mRNA的剪接。然而,SF2/ASF介导的剪接激活依赖于N1外显子增强子元件,而SC35介导的激活则不依赖于此。与SF2/ASF不同,并且与其他系统一致,hnRNP A1在体外抑制c-src剪接。将hnRNP A1对剪接的负向活性与PTB(一种先前已证明在该系统中抑制剪接的蛋白质)的负向活性进行了比较。这两种蛋白质都抑制外显子N1的剪接,并且都能抵消SR蛋白的增强活性。去除N1上游的PTB结合位点可防止PTB介导的抑制作用,但不影响A1介导的抑制作用。因此,hnRNP A1和PTB使用不同的机制来抑制c-src剪接。我们的研究结果将这些著名的外显子剪接调节因子SF2/ASF和hnRNP A1的活性与主要受内含子因子控制的外显子剪接联系起来。